CLDX vs CMS · rev $7.0M vs P/E 20, $22.42B cap
Celldex Therapeutics Inc (CLDX) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported CLDX revenue for 2024-12-31 was $7.0M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CLDX currently screens at market cap $2.35B.
CMS does not have a complete income-statement cache yet.
CLDX currently screens at market cap $2.35B. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the CLDX and CMS stock pages for the full models.
Not investment advice.